Jay Campbell
Directeur/Bestuurslid bij Update Pharma, Inc.
Oorsprong van het eerstegraads netwerk van Jay Campbell
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Update Pharma, Inc.
 Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013.
1
| Subsidiary | Medical Distributors | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jay Campbell via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Paramount Capital, Inc. | Corporate Officer/Principal | ||
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman | |
Igxbio, Inc.
 Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Pharmaceuticals: Major | Founder | |
| KINTARA THERAPEUTICS, INC. | Biotechnology | Founder | |
| New York Medical College | College/University | Doctorate Degree | |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Pharmaceuticals: Major | Founder | |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Medical Distributors | Corporate Officer/Principal | |
EGB Ventures LLC
 EGB Ventures LLC Investment ManagersFinance EGB Ventures LLC EGB Ventures) is a venture capital firm founded in 2010 by William (Bill) Garner. The firm is headquartered in Whitewright, Texas. | Investment Managers | Founder | |
Del Mar Pharmaceuticals (BC) Ltd.
 Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Part of Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. provides drug development services. The company is based in Vancouver, Canada. The Canadian company was founded by William James Garner, Jeffrey A. Bacha, Dennis M. Brown. Jeffrey A. Bacha has been the CEO since incorporation. Del Mar Pharmaceuticals (BC was acquired by Kintara Therapeutics, Inc. on January 25, 2013 for $0.65 million. | Pharmaceuticals: Major | Founder | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| INVION LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| Innovation Angel Foundation, Inc. | Director/Board Member | ||
| RACE ONCOLOGY LIMITED | Pharmaceuticals: Major | Founder | |
ISLA Pharamceuticals
 ISLA Pharamceuticals Pharmaceuticals: MajorHealth Technology ISLA Pharmaceuticals develops therapies for tropical diseases. The private company is based in Puerto Rico. The American company was founded by William James Garner. | Pharmaceuticals: Major | Founder | |
| TRYPTAMINE THERAPEUTICS LIMITED | Pharmaceuticals: Major | Founder | |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Miscellaneous Commercial Services | Founder | |
| GENETETHER THERAPEUTICS INC. | Biotechnology | Founder |
Statistieken
Internationaal
| Verenigde Staten | 16 |
| Canada | 5 |
| Australië | 3 |
Sectoraal
| Health Technology | 15 |
| Consumer Services | 3 |
| Distribution Services | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Operationeel
| Founder | 14 |
| Director/Board Member | 11 |
| Chairman | 6 |
| President | 3 |
| Corporate Officer/Principal | 3 |
Sterkste connecties
| Insiders | |
|---|---|
| Garner William | 22 |
- Beurs
- Insiders
- Jay Campbell
- Bedrijfsconnecties
